EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018?

Sohei Satoi, Tomohisa Yamamoto, Yoichi Matsui

Journal of Pancreatology · 2018

DOI: 10.1097/jp9.0000000000000001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pancreatology, 2018. Verfasst von Sohei Satoi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) continues to have a dismal prognosis, with a 5-year survival rate of

Zitieren

APA

Satoi, S., Yamamoto, T., & Matsui, Y. (2018). Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018?. Journal of Pancreatology. https://doi.org/10.1097/jp9.0000000000000001

Vancouver

Satoi S, Yamamoto T, Matsui Y. Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018?. Journal of Pancreatology. 2018. doi:10.1097/jp9.0000000000000001

BibTeX
@article{Satoi2018,
  author = {Satoi, Sohei and Yamamoto, Tomohisa and Matsui, Yoichi},
  title = {Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018?},
  journal = {Journal of Pancreatology},
  year = {2018},
  doi = {10.1097/jp9.0000000000000001}
}
Kostenlos starten →